Search all medical codes

Moderna Covid-19 Vaccine Administration - First Dose

CPT4 code

Name of the Procedure:

Moderna Covid-19 Vaccine Administration - First Dose (mRNA-1273)

Summary

The Moderna COVID-19 vaccine first dose is a preventive vaccination aimed at reducing the risk of contracting COVID-19. It involves the intramuscular injection of a portion of the SARS-CoV-2 virus's mRNA, which helps the body recognize and fight the virus.

Purpose

The procedure aims to build immunity against COVID-19 to prevent infection and reduce the severity of the disease. The vaccine trains the immune system to recognize the virus and mount a defense against it.

Indications

  • Individuals aged 18 and older.
  • People without contraindications to the vaccine.
  • Recommended for those at higher risk of severe COVID-19 infection due to underlying health conditions or occupational exposure.

Preparation

  • No specific preparation such as fasting is required.
  • Ensure you are not currently experiencing symptoms of COVID-19.
  • Inform healthcare providers of any allergies or medical conditions.
  • Wear a mask and follow social distancing guidelines at the vaccination site.

Procedure Description

  1. Verification and Consent: Your identity and eligibility will be verified. You will also be given information about the vaccine and asked to sign a consent form.
  2. Administration: A healthcare professional will administer an intramuscular injection of the vaccine, usually in the deltoid muscle of the upper arm.
  3. Observation: You will be monitored for 15-30 minutes post-vaccination to ensure there are no adverse reactions.

Duration

The entire process, including observation, typically takes about 30-45 minutes.

Setting

The procedure is usually performed in a clinic, pharmacy, or designated vaccination site.

Personnel

  • Nurses
  • Medical assistants
  • Pharmacists

Risks and Complications

  • Common: Pain at the injection site, fatigue, headache, muscle pain, chills, fever, and nausea.
  • Rare: Severe allergic reactions (anaphylaxis), myocarditis, with appropriate medical care available on-site for management.

Benefits

  • Significant reduction in the risk of contracting COVID-19.
  • Lower likelihood of severe illness if infected.
  • Immunity generally begins to build within two weeks after the first dose.

Recovery

  • Post-vaccination, patients are advised to rest if they feel unwell.
  • Use of over-the-counter pain relievers like acetaminophen or ibuprofen may be recommended for managing minor side effects.
  • Normal activities can usually be resumed immediately, but heavy exercise should be avoided for a day or two.

Alternatives

  • Other COVID-19 vaccines such as Pfizer-BioNTech or Johnson & Johnson.
  • Pros: Some vaccines might offer slightly different efficacy rates.
  • Cons: Availability and personal health conditions might limit options.

Patient Experience

  • During the procedure: Momentary discomfort from the needle injection.
  • After the procedure: Some may experience minor side effects like soreness at the injection site, fatigue, and mild flu-like symptoms. These symptoms typically resolve within a few days.
  • Comfort measures include hydration, rest, and over-the-counter pain relievers if needed.

Similar Codes